Home›Stock Screener›Indo Amines›Intrinsic Value

Indo Amines Intrinsic Value

Indo Amines intrinsic value. Indo Amines (INDOAMIN) median intrinsic value is ₹163.98 from 10 valuation models (range ₹43–₹298), vs current price ₹143.31 — +14.4% upside (Trading Below Median Value), margin of safety 12.6%. Compare with INDOAMIN stock valuation models to assess whether the stock is under or overvalued.

Market Price (CMP)
₹143.31
Primary Intrinsic Value
₹131.04
Market Cap
₹515.9 Cr
+14.4% Upside
Median Value
₹163.98
Value Range
₹43 - ₹298
Assessment
Trading Below Median Value
Safety Margin
12.6%

INDOAMIN Valuation Methods Summary — DCF, Graham Number & P/E

Indo Amines intrinsic value across 10 models vs current price ₹143.31 — upside/downside and value range per method. For current market price and key ratios, visit INDOAMIN share price screener.

Method Type Intrinsic Value Range Upside/Downside Details
P/E Based Valuation earnings ₹131.04 ₹104.83 - ₹157.25 -8.6% EPS: ₹10.92, Sector P/E: 12x
Book Value Method asset ₹109.44 ₹98.50 - ₹120.38 -23.6% Book Value/Share: ₹109.44, P/B: 1.0x
Revenue Multiple Method revenue ₹286.62 ₹257.96 - ₹315.28 +100.0% Revenue/Share: ₹360.00, P/S: 0.8x
EBITDA Multiple Method earnings ₹266.67 ₹240.00 - ₹293.34 +86.1% EBITDA: ₹160.00Cr, EV/EBITDA: 6x
Simple DCF (5Y) dcf ₹298.08 ₹238.46 - ₹357.70 +108.0% CF Growth: 15.0%, Discount: 15%
PEG Ratio Method growth ₹69.89 ₹62.90 - ₹76.88 -51.2% EPS Growth: 8.0%, Fair P/E: 6.4x
Growth Adjusted P/E growth ₹89.98 ₹80.98 - ₹98.98 -37.2% Revenue Growth: 6.0%, Adj P/E: 8.2x
ROE Based Valuation profitability ₹286.62 ₹257.96 - ₹315.28 +100.0% ROE: 21.3%, P/E Multiple: 16x
Graham Defensive Method conservative ₹163.98 ₹147.58 - ₹180.38 +14.4% EPS: ₹10.92, BVPS: ₹109.44
Dividend Yield Method dividend ₹42.99 ₹38.69 - ₹47.29 -70.0% DPS: ₹0.50, Target Yield: 3.5%
Method Types: Earnings Asset DCF Growth Dividend Conservative

INDOAMIN Intrinsic Value vs Market Price — All Valuation Models

Indo Amines fair value range ₹43–₹298 vs current market price ₹143.31 across 10 valuation models. Read INDOAMIN dividend payout details for the complete payout history and dividend yield track record.

INDOAMIN Intrinsic Value Analysis — Undervalued or Overvalued?

Indo Amines median intrinsic value ₹163.98, current price ₹143.31 — Trading Below Median Value by 14.4%, margin of safety 12.6%.

What is the intrinsic value of INDOAMIN?

Based on our comprehensive analysis using 10 different valuation methods, the estimated intrinsic value of Indo Amines (INDOAMIN) is ₹163.98 (median value). With the current market price of ₹143.31, this represents a +14.4% variance from our estimated fair value.

The valuation range spans from ₹42.99 to ₹298.08, indicating ₹42.99 - ₹298.08.

Is INDOAMIN undervalued or overvalued?

Based on our multi-method analysis, Indo Amines (INDOAMIN) appears to be trading below median value by approximately 14.4%.

INDOAMIN Financial Health — Key Ratios vs Industry Benchmarks

Indo Amines financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.

Financial Metric Current Value Industry Benchmark Assessment Impact on Valuation
Current Ratio 5.46 Industry Standard: 2.0+ Above 2.0 Measures short-term liquidity capacity
Return on Equity 21.3% Industry Standard: 15%+ Above 15% Measures shareholder return efficiency
Operating Margin 11.0% Industry Standard: 20%+ Above 10% Indicates operational efficiency level
Asset Turnover Ratio 1.44x Industry Standard: 1.0x+ Above 1.0x Measures asset utilization efficiency

INDOAMIN Cash Flow Quality — Operating & Free Cash Flow

Indo Amines operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.

Period Operating Cash Flow Free Cash Flow Cash Flow Quality Sustainability Score
March 2026 ₹79 Cr ₹44 Cr Positive Free Cash Flow 8/10
March 2025 ₹35 Cr ₹-6 Cr Positive Operating Cash Flow 6/10
March 2024 ₹70 Cr ₹57 Cr Positive Free Cash Flow 8/10
March 2023 ₹20 Cr ₹5 Cr Positive Free Cash Flow 7/10
March 2022 ₹16 Cr ₹-4 Cr Positive Operating Cash Flow 6/10